CIK: 1697536 - Address: C/O First Wave Biopharma, Inc, 777 Yamato Road, Suite 502, Boca Raton, FL 33431
10 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y

4/3/24 17:13
4/1/24
FWBIFirst Wave Biopharma, Inc.DEHealthDrugPharmaceutical PreparationsRomano SarahFLOCFOS04.2300019D
3/19/24 16:10
3/15/24
FWBIFirst Wave Biopharma, Inc.DEHealthDrugPharmaceutical PreparationsRomano SarahFLOCFOS-64.960-1-619D
1/17/24 16:02
1/12/24
FWBIFirst Wave Biopharma, Inc.DEHealthDrugPharmaceutical PreparationsRomano SarahFLOCFOS04.2000020D
10/6/23 16:05
10/4/23
FWBIFirst Wave Biopharma, Inc.DEHealthDrugPharmaceutical PreparationsRomano SarahFLOCFOS00.29000-2-1016D
7/5/23 16:28
7/3/23
FWBIFirst Wave Biopharma, Inc.DEHealthDrugPharmaceutical PreparationsRomano SarahFLOCFOS-31.540-2-1017D
4/5/23 16:17
4/3/23
FWBIFirst Wave Biopharma, Inc.DEHealthDrugPharmaceutical PreparationsRomano SarahFLOCFOS-52.500-2-919D
7/15/19 20:39
7/11/19
EYEGEyegate Pharmaceuticals IncDEHealthDrugPharmaceutical PreparationsRomano SarahMAOCFOS.m-50.23640-20-7262D
4/18/18 17:22
4/17/18
EYEGEyegate Pharmaceuticals IncDEHealthDrugPharmaceutical PreparationsRomano SarahMAOCFOP.d00.00063141107D
8/17/17 16:05
8/15/17
EYEGEyegate Pharmaceuticals IncDEHealthDrugPharmaceutical PreparationsRomano SarahMAOInterim P101.000104433D
6/14/17 16:51
6/14/17
EYEGEyegate Pharmaceuticals IncDEHealthDrugPharmaceutical PreparationsRomano SarahMAOInterim P.d00.0002080023D

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact